Back to search results

ACHIEVE-HF Study for Heart Failure and High Blood Pressure

This study, called ACHIEVE-HF, is looking for Detroit-area residents aged 18 or older with high blood pressure (hypertension) or certain risk factors for heart failure. It aims to improve heart health by testing two approaches: PAL2, a program delivered by community health workers to help with lifestyle changes and health education, and PHARM-PAL2, where a study pharmacist will prescribe blood pressure medication following standard medical guidelines. The main goals are to see if these interventions can lower your systolic blood pressure and a heart-related biomarker called NT-proBNP after 12 months. The study is part of a larger effort to reduce health differences in Detroit and Cleveland.

Study design
This interventional study plans to enroll 364 participants. The phase of the study is not specified.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will measure your blood pressure and NT-proBNP levels at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05330221

Project 2: ACHIEVE- HF

Active, Not Recruiting
NAAges 18+InterventionalPrevention
Henry Ford Health System
~364 participants
Updated 2026-09-01 on ClinicalTrials.gov
What's tested:PAL2PHARM-PAL2

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Systolic blood pressure (BP)
Measured over 12 months
+1 more outcome measured

Conditions

Heart Failure
Hypertension

Explore related trials

Heart FailureHypertension

NCT05330221

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Wayne State University

    Detroit, Michiganno site contact published

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Systolic blood pressure (BP)12 months

    Change in systolic BP at 12-months vs. baseline (detect ≥ 5 mm Hg difference). This will be determined by comparing the "post-trial systolic BP" at 12-month mobile health unit (MHU) visit versus the "baseline systolic BP" at screening MHU visit.

  • NT-proB-type Natriuretic Peptide (NT-proBNP)12 months

    Change in NT-proBNP over 12 months